Hims & Hers Declines - How The GLP-1 Market Shift Affects Growth
Hims & Hers plans to launch a generic version of liraglutide, but its efficacy is significantly lower than semaglutide. See ...
Jim Cramer Says Hims & Hers Health, Inc. (HIMS) Has ‘Become A True Battleground’
Stocks in Focus. In this article, we are going to take a look at where Hims & Hers Health, Inc. (NYSE:HIMS) stands against ...
Hosted on MSN1h
Hims & Hers Retail Traders Eye Robust Post-Earnings Rebound Following Stock’s Worst Drop On Semaglutide Update
Hims & Hers Health Inc. (HIMS) stock tumbled over 25% on Friday, extending losses in after-hours trading after the U.S. Food ...
Barron's7h
Barron’s Stock Picks
Here is how the Barron’s Roundtable members’ picks performed. Find investment ideas for your portfolio with the latest stock picks from Barron’s below. These picks are the product of the ...
Yahoo Finance13h
Yahoo Finance – stock market live, quotes, business and finance news
Palantir stock fell more than 10% Wednesday following a report the Trump administration is planning deep cuts to the defense budget. The "DOGE" efficiency commission has begun posting details of the ...